Fiduciary Management Inc’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,164,442
Closed -$57.3M 75
2022
Q1
$57.3M Buy
1,164,442
+207,021
+22% +$10.9M 0.46% 59
2021
Q4
$53.4M Sell
957,421
-27,174
-3% -$1.49M 0.39% 55
2021
Q3
$57.2M Sell
984,595
-76,813
-7% -$4.73M 0.43% 52
2021
Q2
$67.1M Sell
1,061,408
-151,203
-12% -$9.96M 0.49% 50
2021
Q1
$77.4M Sell
1,212,611
-153,463
-11% -$8.9M 0.58% 43
2020
Q4
$71.5M Buy
1,366,074
+35,048
+3% +$1.73M 0.54% 45
2020
Q3
$58.2M Sell
1,331,026
-61,004
-4% -$2.7M 0.48% 45
2020
Q2
$61.3M Buy
1,392,030
+163,473
+13% +$6.91M 0.51% 45
2020
Q1
$47.7M Buy
+1,228,557
New +$62.6M 0.42% 53

Other funds holding XRAY

Fiduciary Management Inc's XRAY Position: Q2 2022 in Review

Fiduciary Management Inc sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 1,164,442 shares — an estimated $57.3M sold.

Fiduciary Management Inc first reported a position in XRAY in Q1 2020 and held it in 9 quarters. The position peaked at $77.4M in Q1 2021. 470 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.

  • Fiduciary Management Inc reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
  • Fiduciary Management Inc sold 1,164,442 Dentsply Sirona shares in Q2 2022, an estimated $57.3M.
  • Fiduciary Management Inc first reported a position in Dentsply Sirona in Q1 2020 and held it in 9 quarters.
  • Fiduciary Management Inc's Dentsply Sirona position peaked at $77.4M in Q1 2021.
  • 470 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.

Based on Fiduciary Management Inc's 13F filing for Q2 2022, filed 12 Aug 2022.